Cosmetic results for patients with breast cancer operated with bilateral reduction mammoplasty

Not Applicable

Completed

• Conditions: Cosmetic outcome after breast cancer surgery; Surgery

• Registration Number: ISRCTN82786416
• Lead Sponsor: Region Skåne

Brief Summary

2021 results in https://doi.org/10.1007/s00268-020-05941-0 (added 05/02/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-10-01
• Study Start: 2019-11-08
• Last Update Posted: 16 February 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 146

Inclusion Criteria

All patients operated with bilateral therapeutic mammoplasty between 2011 and August 2018 in Centralsjukhuset Kristianstad

Exclusion Criteria

1. Patients who had a mastectomy before the 1-year postoperative follow-up
2. Patients who had a nipple removed during the surgery due to tumor location
3. Patients where the postoperative 1-year photos were missing
4. Patients who died before the 1-year follow-up

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Cosmetic outcome measured using BCCT.core score on a 4-grade scale 1-year postoperatively<br> 2. Symmetry measurements from BCCT.core preoperative and 1-year postoperative<br> 3. Patient's cosmetic scores on a scale of 1-10 at 1-year postoperatively<br> 4. Surgeon's cosmetic scores on a scale of 1-10 at 1-year postoperatively<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. Complications documented for each breast separately according to Clavien-Dindo classification 2 weeks postoperatively and 1 year postoperatively<br> 2. Breast size in ml measured using plastic breast cups preoperatively<br> 3. Breast measurements in cm measured using measuring tape preoperatively<br> 4. Percentage of breast excised during surgery measured by dividing the weight of the breast tissue excised in surgery with the weight of the breast<br> 5. Axillary dissection in surgery, measured by if there was an axillary clearance or not<br> 6. Tumor characteristics in pathology answers measured using pathology reports 2 weeks postoperatively<br>